Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort studySusana Monge, Virgilio Yagüe Galaup, Eliseo Pastor Villalba et al.|The Lancet Infectious Diseases|2022Cited by 84
The Impact of COVID-19 on Mortality in Spain: Monitoring Excess Mortality (MoMo) and the Surveillance of Confirmed COVID-19 DeathsInmaculada León-Gómez, Amparo Larrauri, Clara Mazagatos et al.|Viruses|2021Cited by 21
Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021David García-García, Diana Gómez‐Barroso, Herranz-Hernandez Rafael et al.|Eurosurveillance|2022Cited by 19
Perimeter confinements of basic health zones and COVID-19 incidence in Madrid, SpainDavid García-García, Diana Gómez‐Barroso, Herranz-Hernandez Rafael et al.|BMC Public Health|2022Cited by 9
Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other VariantsSusana Monge, Virgilio Yagüe Galaup, Ayelén Rojas‐Benedicto et al.|Clinical Infectious Diseases|2022Cited by 9